COVID-19 Impact on Global Small Molecule Active Pharmaceutical Ingredient, Market Insights and Forecast to 2026
Small Molecule Active Pharmaceutical Ingredient market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Small Molecule Active Pharmaceutical Ingredient market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Small Molecule Active Pharmaceutical Ingredient market is segmented into
The Small Molecule Active Pharmaceutical Ingredient market is analysed and market size information is provided by regions (countries).
The key regions covered in the Small Molecule Active Pharmaceutical Ingredient market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Small Molecule Active Pharmaceutical Ingredient Market Share Analysis
Small Molecule Active Pharmaceutical Ingredient market competitive landscape provides details and data information by players.
The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Small Molecule Active Pharmaceutical Ingredient business, the date to enter into the Small Molecule Active Pharmaceutical Ingredient market, Small Molecule Active Pharmaceutical Ingredient product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Small Molecule Active Pharmaceutical Ingredient market is segmented into
- Standard API
- High Potency API
- Cardiovascular Diseases
- Respiratory Disorders
- Infectious Diseases
- Others
The Small Molecule Active Pharmaceutical Ingredient market is analysed and market size information is provided by regions (countries).
The key regions covered in the Small Molecule Active Pharmaceutical Ingredient market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Small Molecule Active Pharmaceutical Ingredient Market Share Analysis
Small Molecule Active Pharmaceutical Ingredient market competitive landscape provides details and data information by players.
The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Small Molecule Active Pharmaceutical Ingredient business, the date to enter into the Small Molecule Active Pharmaceutical Ingredient market, Small Molecule Active Pharmaceutical Ingredient product introduction, recent developments, etc.
The major vendors covered:
- Johnson Matthey
- Siegfried Holding AG
- Pfizer
- Sanofi S.A.
- Novartis AG,
- Bristol-Myers Squibb
- Boehringer Ingelheim GmbH
- GlaxoSmithKline
- Albany Molecular Research Inc.
- Bachem Holding AG
- PCAS
- Patheon N.V.
- AstraZeneca
- Johnson & Johnson
- Merck & Co
- BASF SE
- Catalent Inc.
- Teva Pharmaceuticals
- Roche
- Cambrex Corporation
- GILEAD Science Inc.
1 STUDY COVERAGE
1.1 Small Molecule Active Pharmaceutical Ingredient Product Introduction
1.2 Market Segments
1.3 Key Small Molecule Active Pharmaceutical Ingredient Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size Growth Rate by Type
1.4.2 Standard API
1.4.3 High Potency API
1.5 Market by Application
1.5.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size Growth Rate by Application
1.5.2 Cardiovascular Diseases
1.5.3 Respiratory Disorders
1.5.4 Infectious Diseases
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Small Molecule Active Pharmaceutical Ingredient Industry Impact
1.6.1 How the Covid-19 is Affecting the Small Molecule Active Pharmaceutical Ingredient Industry
1.6.1.1 Small Molecule Active Pharmaceutical Ingredient Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Small Molecule Active Pharmaceutical Ingredient Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Small Molecule Active Pharmaceutical Ingredient Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size Estimates and Forecasts
2.1.1 Global Small Molecule Active Pharmaceutical Ingredient Revenue 2015-2026
2.1.2 Global Small Molecule Active Pharmaceutical Ingredient Sales 2015-2026
2.2 Small Molecule Active Pharmaceutical Ingredient Market Size by Region: 2020 Versus 2026
2.2.1 Global Small Molecule Active Pharmaceutical Ingredient Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Small Molecule Active Pharmaceutical Ingredient Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL SMALL MOLECULE ACTIVE PHARMACEUTICAL INGREDIENT COMPETITOR LANDSCAPE BY PLAYERS
3.1 Small Molecule Active Pharmaceutical Ingredient Sales by Manufacturers
3.1.1 Small Molecule Active Pharmaceutical Ingredient Sales by Manufacturers (2015-2020)
3.1.2 Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Manufacturers (2015-2020)
3.2 Small Molecule Active Pharmaceutical Ingredient Revenue by Manufacturers
3.2.1 Small Molecule Active Pharmaceutical Ingredient Revenue by Manufacturers (2015-2020)
3.2.2 Small Molecule Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Small Molecule Active Pharmaceutical Ingredient Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Small Molecule Active Pharmaceutical Ingredient Revenue in 2019
3.2.5 Global Small Molecule Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Small Molecule Active Pharmaceutical Ingredient Price by Manufacturers
3.4 Small Molecule Active Pharmaceutical Ingredient Manufacturing Base Distribution, Product Types
3.4.1 Small Molecule Active Pharmaceutical Ingredient Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Small Molecule Active Pharmaceutical Ingredient Product Type
3.4.3 Date of International Manufacturers Enter into Small Molecule Active Pharmaceutical Ingredient Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size by Type (2015-2020)
4.1.1 Global Small Molecule Active Pharmaceutical Ingredient Sales by Type (2015-2020)
4.1.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue by Type (2015-2020)
4.1.3 Small Molecule Active Pharmaceutical Ingredient Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Small Molecule Active Pharmaceutical Ingredient Market Size Forecast by Type (2021-2026)
4.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Type (2021-2026)
4.2.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Type (2021-2026)
4.2.3 Small Molecule Active Pharmaceutical Ingredient Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Small Molecule Active Pharmaceutical Ingredient Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size by Application (2015-2020)
5.1.1 Global Small Molecule Active Pharmaceutical Ingredient Sales by Application (2015-2020)
5.1.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue by Application (2015-2020)
5.1.3 Small Molecule Active Pharmaceutical Ingredient Price by Application (2015-2020)
5.2 Small Molecule Active Pharmaceutical Ingredient Market Size Forecast by Application (2021-2026)
5.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Application (2021-2026)
5.2.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Application (2021-2026)
5.2.3 Global Small Molecule Active Pharmaceutical Ingredient Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Small Molecule Active Pharmaceutical Ingredient by Country
6.1.1 North America Small Molecule Active Pharmaceutical Ingredient Sales by Country
6.1.2 North America Small Molecule Active Pharmaceutical Ingredient Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Type
6.3 North America Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Application
7 EUROPE
7.1 Europe Small Molecule Active Pharmaceutical Ingredient by Country
7.1.1 Europe Small Molecule Active Pharmaceutical Ingredient Sales by Country
7.1.2 Europe Small Molecule Active Pharmaceutical Ingredient Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Type
7.3 Europe Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Small Molecule Active Pharmaceutical Ingredient by Region
8.1.1 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales by Region
8.1.2 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Type
8.3 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Small Molecule Active Pharmaceutical Ingredient by Country
9.1.1 Latin America Small Molecule Active Pharmaceutical Ingredient Sales by Country
9.1.2 Latin America Small Molecule Active Pharmaceutical Ingredient Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Type
9.3 Central & South America Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient by Country
10.1.1 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales by Country
10.1.2 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Type
10.3 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Johnson Matthey
11.1.1 Johnson Matthey Corporation Information
11.1.2 Johnson Matthey Description, Business Overview and Total Revenue
11.1.3 Johnson Matthey Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Products Offered
11.1.5 Johnson Matthey Recent Development
11.2 Siegfried Holding AG
11.2.1 Siegfried Holding AG Corporation Information
11.2.2 Siegfried Holding AG Description, Business Overview and Total Revenue
11.2.3 Siegfried Holding AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Products Offered
11.2.5 Siegfried Holding AG Recent Development
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description, Business Overview and Total Revenue
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Small Molecule Active Pharmaceutical Ingredient Products Offered
11.3.5 Pfizer Recent Development
11.4 Sanofi S.A.
11.4.1 Sanofi S.A. Corporation Information
11.4.2 Sanofi S.A. Description, Business Overview and Total Revenue
11.4.3 Sanofi S.A. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Products Offered
11.4.5 Sanofi S.A. Recent Development
11.5 Novartis AG,
11.5.1 Novartis AG, Corporation Information
11.5.2 Novartis AG, Description, Business Overview and Total Revenue
11.5.3 Novartis AG, Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Products Offered
11.5.5 Novartis AG, Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Corporation Information
11.6.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
11.6.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Products Offered
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Boehringer Ingelheim GmbH
11.7.1 Boehringer Ingelheim GmbH Corporation Information
11.7.2 Boehringer Ingelheim GmbH Description, Business Overview and Total Revenue
11.7.3 Boehringer Ingelheim GmbH Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Products Offered
11.7.5 Boehringer Ingelheim GmbH Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Corporation Information
11.8.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.8.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.8.4 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Products Offered
11.8.5 GlaxoSmithKline Recent Development
11.9 Albany Molecular Research Inc.
11.9.1 Albany Molecular Research Inc. Corporation Information
11.9.2 Albany Molecular Research Inc. Description, Business Overview and Total Revenue
11.9.3 Albany Molecular Research Inc. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Products Offered
11.9.5 Albany Molecular Research Inc. Recent Development
11.10 Bachem Holding AG
11.10.1 Bachem Holding AG Corporation Information
11.10.2 Bachem Holding AG Description, Business Overview and Total Revenue
11.10.3 Bachem Holding AG Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Products Offered
11.10.5 Bachem Holding AG Recent Development
11.1 Johnson Matthey
11.1.1 Johnson Matthey Corporation Information
11.1.2 Johnson Matthey Description, Business Overview and Total Revenue
11.1.3 Johnson Matthey Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Products Offered
11.1.5 Johnson Matthey Recent Development
11.12 Patheon N.V.
11.12.1 Patheon N.V. Corporation Information
11.12.2 Patheon N.V. Description, Business Overview and Total Revenue
11.12.3 Patheon N.V. Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Patheon N.V. Products Offered
11.12.5 Patheon N.V. Recent Development
11.13 AstraZeneca
11.13.1 AstraZeneca Corporation Information
11.13.2 AstraZeneca Description, Business Overview and Total Revenue
11.13.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.13.4 AstraZeneca Products Offered
11.13.5 AstraZeneca Recent Development
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Corporation Information
11.14.2 Johnson & Johnson Description, Business Overview and Total Revenue
11.14.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Johnson & Johnson Products Offered
11.14.5 Johnson & Johnson Recent Development
11.15 Merck & Co
11.15.1 Merck & Co Corporation Information
11.15.2 Merck & Co Description, Business Overview and Total Revenue
11.15.3 Merck & Co Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Merck & Co Products Offered
11.15.5 Merck & Co Recent Development
11.16 BASF SE
11.16.1 BASF SE Corporation Information
11.16.2 BASF SE Description, Business Overview and Total Revenue
11.16.3 BASF SE Sales, Revenue and Gross Margin (2015-2020)
11.16.4 BASF SE Products Offered
11.16.5 BASF SE Recent Development
11.17 Catalent Inc.
11.17.1 Catalent Inc. Corporation Information
11.17.2 Catalent Inc. Description, Business Overview and Total Revenue
11.17.3 Catalent Inc. Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Catalent Inc. Products Offered
11.17.5 Catalent Inc. Recent Development
11.18 Teva Pharmaceuticals
11.18.1 Teva Pharmaceuticals Corporation Information
11.18.2 Teva Pharmaceuticals Description, Business Overview and Total Revenue
11.18.3 Teva Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Teva Pharmaceuticals Products Offered
11.18.5 Teva Pharmaceuticals Recent Development
11.19 Roche
11.19.1 Roche Corporation Information
11.19.2 Roche Description, Business Overview and Total Revenue
11.19.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Roche Products Offered
11.19.5 Roche Recent Development
11.20 Cambrex Corporation
11.20.1 Cambrex Corporation Corporation Information
11.20.2 Cambrex Corporation Description, Business Overview and Total Revenue
11.20.3 Cambrex Corporation Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Cambrex Corporation Products Offered
11.20.5 Cambrex Corporation Recent Development
11.21 GILEAD Science Inc.
11.21.1 GILEAD Science Inc. Corporation Information
11.21.2 GILEAD Science Inc. Description, Business Overview and Total Revenue
11.21.3 GILEAD Science Inc. Sales, Revenue and Gross Margin (2015-2020)
11.21.4 GILEAD Science Inc. Products Offered
11.21.5 GILEAD Science Inc. Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Small Molecule Active Pharmaceutical Ingredient Market Estimates and Projections by Region
12.1.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Regions 2021-2026
12.1.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Regions 2021-2026
12.2 North America Small Molecule Active Pharmaceutical Ingredient Market Size Forecast (2021-2026)
12.2.1 North America: Small Molecule Active Pharmaceutical Ingredient Sales Forecast (2021-2026)
12.2.2 North America: Small Molecule Active Pharmaceutical Ingredient Revenue Forecast (2021-2026)
12.2.3 North America: Small Molecule Active Pharmaceutical Ingredient Market Size Forecast by Country (2021-2026)
12.3 Europe Small Molecule Active Pharmaceutical Ingredient Market Size Forecast (2021-2026)
12.3.1 Europe: Small Molecule Active Pharmaceutical Ingredient Sales Forecast (2021-2026)
12.3.2 Europe: Small Molecule Active Pharmaceutical Ingredient Revenue Forecast (2021-2026)
12.3.3 Europe: Small Molecule Active Pharmaceutical Ingredient Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Small Molecule Active Pharmaceutical Ingredient Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Small Molecule Active Pharmaceutical Ingredient Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Small Molecule Active Pharmaceutical Ingredient Market Size Forecast by Region (2021-2026)
12.5 Latin America Small Molecule Active Pharmaceutical Ingredient Market Size Forecast (2021-2026)
12.5.1 Latin America: Small Molecule Active Pharmaceutical Ingredient Sales Forecast (2021-2026)
12.5.2 Latin America: Small Molecule Active Pharmaceutical Ingredient Revenue Forecast (2021-2026)
12.5.3 Latin America: Small Molecule Active Pharmaceutical Ingredient Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Small Molecule Active Pharmaceutical Ingredient Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Small Molecule Active Pharmaceutical Ingredient Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Small Molecule Active Pharmaceutical Ingredient Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Small Molecule Active Pharmaceutical Ingredient Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Small Molecule Active Pharmaceutical Ingredient Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Small Molecule Active Pharmaceutical Ingredient Product Introduction
1.2 Market Segments
1.3 Key Small Molecule Active Pharmaceutical Ingredient Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size Growth Rate by Type
1.4.2 Standard API
1.4.3 High Potency API
1.5 Market by Application
1.5.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size Growth Rate by Application
1.5.2 Cardiovascular Diseases
1.5.3 Respiratory Disorders
1.5.4 Infectious Diseases
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Small Molecule Active Pharmaceutical Ingredient Industry Impact
1.6.1 How the Covid-19 is Affecting the Small Molecule Active Pharmaceutical Ingredient Industry
1.6.1.1 Small Molecule Active Pharmaceutical Ingredient Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Small Molecule Active Pharmaceutical Ingredient Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Small Molecule Active Pharmaceutical Ingredient Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size Estimates and Forecasts
2.1.1 Global Small Molecule Active Pharmaceutical Ingredient Revenue 2015-2026
2.1.2 Global Small Molecule Active Pharmaceutical Ingredient Sales 2015-2026
2.2 Small Molecule Active Pharmaceutical Ingredient Market Size by Region: 2020 Versus 2026
2.2.1 Global Small Molecule Active Pharmaceutical Ingredient Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Small Molecule Active Pharmaceutical Ingredient Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL SMALL MOLECULE ACTIVE PHARMACEUTICAL INGREDIENT COMPETITOR LANDSCAPE BY PLAYERS
3.1 Small Molecule Active Pharmaceutical Ingredient Sales by Manufacturers
3.1.1 Small Molecule Active Pharmaceutical Ingredient Sales by Manufacturers (2015-2020)
3.1.2 Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Manufacturers (2015-2020)
3.2 Small Molecule Active Pharmaceutical Ingredient Revenue by Manufacturers
3.2.1 Small Molecule Active Pharmaceutical Ingredient Revenue by Manufacturers (2015-2020)
3.2.2 Small Molecule Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Small Molecule Active Pharmaceutical Ingredient Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Small Molecule Active Pharmaceutical Ingredient Revenue in 2019
3.2.5 Global Small Molecule Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Small Molecule Active Pharmaceutical Ingredient Price by Manufacturers
3.4 Small Molecule Active Pharmaceutical Ingredient Manufacturing Base Distribution, Product Types
3.4.1 Small Molecule Active Pharmaceutical Ingredient Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Small Molecule Active Pharmaceutical Ingredient Product Type
3.4.3 Date of International Manufacturers Enter into Small Molecule Active Pharmaceutical Ingredient Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size by Type (2015-2020)
4.1.1 Global Small Molecule Active Pharmaceutical Ingredient Sales by Type (2015-2020)
4.1.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue by Type (2015-2020)
4.1.3 Small Molecule Active Pharmaceutical Ingredient Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Small Molecule Active Pharmaceutical Ingredient Market Size Forecast by Type (2021-2026)
4.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Type (2021-2026)
4.2.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Type (2021-2026)
4.2.3 Small Molecule Active Pharmaceutical Ingredient Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Small Molecule Active Pharmaceutical Ingredient Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size by Application (2015-2020)
5.1.1 Global Small Molecule Active Pharmaceutical Ingredient Sales by Application (2015-2020)
5.1.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue by Application (2015-2020)
5.1.3 Small Molecule Active Pharmaceutical Ingredient Price by Application (2015-2020)
5.2 Small Molecule Active Pharmaceutical Ingredient Market Size Forecast by Application (2021-2026)
5.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Application (2021-2026)
5.2.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Application (2021-2026)
5.2.3 Global Small Molecule Active Pharmaceutical Ingredient Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Small Molecule Active Pharmaceutical Ingredient by Country
6.1.1 North America Small Molecule Active Pharmaceutical Ingredient Sales by Country
6.1.2 North America Small Molecule Active Pharmaceutical Ingredient Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Type
6.3 North America Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Application
7 EUROPE
7.1 Europe Small Molecule Active Pharmaceutical Ingredient by Country
7.1.1 Europe Small Molecule Active Pharmaceutical Ingredient Sales by Country
7.1.2 Europe Small Molecule Active Pharmaceutical Ingredient Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Type
7.3 Europe Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Small Molecule Active Pharmaceutical Ingredient by Region
8.1.1 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales by Region
8.1.2 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Type
8.3 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Small Molecule Active Pharmaceutical Ingredient by Country
9.1.1 Latin America Small Molecule Active Pharmaceutical Ingredient Sales by Country
9.1.2 Latin America Small Molecule Active Pharmaceutical Ingredient Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Type
9.3 Central & South America Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient by Country
10.1.1 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales by Country
10.1.2 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Type
10.3 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Johnson Matthey
11.1.1 Johnson Matthey Corporation Information
11.1.2 Johnson Matthey Description, Business Overview and Total Revenue
11.1.3 Johnson Matthey Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Products Offered
11.1.5 Johnson Matthey Recent Development
11.2 Siegfried Holding AG
11.2.1 Siegfried Holding AG Corporation Information
11.2.2 Siegfried Holding AG Description, Business Overview and Total Revenue
11.2.3 Siegfried Holding AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Products Offered
11.2.5 Siegfried Holding AG Recent Development
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description, Business Overview and Total Revenue
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Small Molecule Active Pharmaceutical Ingredient Products Offered
11.3.5 Pfizer Recent Development
11.4 Sanofi S.A.
11.4.1 Sanofi S.A. Corporation Information
11.4.2 Sanofi S.A. Description, Business Overview and Total Revenue
11.4.3 Sanofi S.A. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Products Offered
11.4.5 Sanofi S.A. Recent Development
11.5 Novartis AG,
11.5.1 Novartis AG, Corporation Information
11.5.2 Novartis AG, Description, Business Overview and Total Revenue
11.5.3 Novartis AG, Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Products Offered
11.5.5 Novartis AG, Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Corporation Information
11.6.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
11.6.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Products Offered
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Boehringer Ingelheim GmbH
11.7.1 Boehringer Ingelheim GmbH Corporation Information
11.7.2 Boehringer Ingelheim GmbH Description, Business Overview and Total Revenue
11.7.3 Boehringer Ingelheim GmbH Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Products Offered
11.7.5 Boehringer Ingelheim GmbH Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Corporation Information
11.8.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.8.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.8.4 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Products Offered
11.8.5 GlaxoSmithKline Recent Development
11.9 Albany Molecular Research Inc.
11.9.1 Albany Molecular Research Inc. Corporation Information
11.9.2 Albany Molecular Research Inc. Description, Business Overview and Total Revenue
11.9.3 Albany Molecular Research Inc. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Products Offered
11.9.5 Albany Molecular Research Inc. Recent Development
11.10 Bachem Holding AG
11.10.1 Bachem Holding AG Corporation Information
11.10.2 Bachem Holding AG Description, Business Overview and Total Revenue
11.10.3 Bachem Holding AG Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Products Offered
11.10.5 Bachem Holding AG Recent Development
11.1 Johnson Matthey
11.1.1 Johnson Matthey Corporation Information
11.1.2 Johnson Matthey Description, Business Overview and Total Revenue
11.1.3 Johnson Matthey Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Products Offered
11.1.5 Johnson Matthey Recent Development
11.12 Patheon N.V.
11.12.1 Patheon N.V. Corporation Information
11.12.2 Patheon N.V. Description, Business Overview and Total Revenue
11.12.3 Patheon N.V. Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Patheon N.V. Products Offered
11.12.5 Patheon N.V. Recent Development
11.13 AstraZeneca
11.13.1 AstraZeneca Corporation Information
11.13.2 AstraZeneca Description, Business Overview and Total Revenue
11.13.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.13.4 AstraZeneca Products Offered
11.13.5 AstraZeneca Recent Development
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Corporation Information
11.14.2 Johnson & Johnson Description, Business Overview and Total Revenue
11.14.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Johnson & Johnson Products Offered
11.14.5 Johnson & Johnson Recent Development
11.15 Merck & Co
11.15.1 Merck & Co Corporation Information
11.15.2 Merck & Co Description, Business Overview and Total Revenue
11.15.3 Merck & Co Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Merck & Co Products Offered
11.15.5 Merck & Co Recent Development
11.16 BASF SE
11.16.1 BASF SE Corporation Information
11.16.2 BASF SE Description, Business Overview and Total Revenue
11.16.3 BASF SE Sales, Revenue and Gross Margin (2015-2020)
11.16.4 BASF SE Products Offered
11.16.5 BASF SE Recent Development
11.17 Catalent Inc.
11.17.1 Catalent Inc. Corporation Information
11.17.2 Catalent Inc. Description, Business Overview and Total Revenue
11.17.3 Catalent Inc. Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Catalent Inc. Products Offered
11.17.5 Catalent Inc. Recent Development
11.18 Teva Pharmaceuticals
11.18.1 Teva Pharmaceuticals Corporation Information
11.18.2 Teva Pharmaceuticals Description, Business Overview and Total Revenue
11.18.3 Teva Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Teva Pharmaceuticals Products Offered
11.18.5 Teva Pharmaceuticals Recent Development
11.19 Roche
11.19.1 Roche Corporation Information
11.19.2 Roche Description, Business Overview and Total Revenue
11.19.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Roche Products Offered
11.19.5 Roche Recent Development
11.20 Cambrex Corporation
11.20.1 Cambrex Corporation Corporation Information
11.20.2 Cambrex Corporation Description, Business Overview and Total Revenue
11.20.3 Cambrex Corporation Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Cambrex Corporation Products Offered
11.20.5 Cambrex Corporation Recent Development
11.21 GILEAD Science Inc.
11.21.1 GILEAD Science Inc. Corporation Information
11.21.2 GILEAD Science Inc. Description, Business Overview and Total Revenue
11.21.3 GILEAD Science Inc. Sales, Revenue and Gross Margin (2015-2020)
11.21.4 GILEAD Science Inc. Products Offered
11.21.5 GILEAD Science Inc. Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Small Molecule Active Pharmaceutical Ingredient Market Estimates and Projections by Region
12.1.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Regions 2021-2026
12.1.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Regions 2021-2026
12.2 North America Small Molecule Active Pharmaceutical Ingredient Market Size Forecast (2021-2026)
12.2.1 North America: Small Molecule Active Pharmaceutical Ingredient Sales Forecast (2021-2026)
12.2.2 North America: Small Molecule Active Pharmaceutical Ingredient Revenue Forecast (2021-2026)
12.2.3 North America: Small Molecule Active Pharmaceutical Ingredient Market Size Forecast by Country (2021-2026)
12.3 Europe Small Molecule Active Pharmaceutical Ingredient Market Size Forecast (2021-2026)
12.3.1 Europe: Small Molecule Active Pharmaceutical Ingredient Sales Forecast (2021-2026)
12.3.2 Europe: Small Molecule Active Pharmaceutical Ingredient Revenue Forecast (2021-2026)
12.3.3 Europe: Small Molecule Active Pharmaceutical Ingredient Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Small Molecule Active Pharmaceutical Ingredient Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Small Molecule Active Pharmaceutical Ingredient Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Small Molecule Active Pharmaceutical Ingredient Market Size Forecast by Region (2021-2026)
12.5 Latin America Small Molecule Active Pharmaceutical Ingredient Market Size Forecast (2021-2026)
12.5.1 Latin America: Small Molecule Active Pharmaceutical Ingredient Sales Forecast (2021-2026)
12.5.2 Latin America: Small Molecule Active Pharmaceutical Ingredient Revenue Forecast (2021-2026)
12.5.3 Latin America: Small Molecule Active Pharmaceutical Ingredient Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Small Molecule Active Pharmaceutical Ingredient Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Small Molecule Active Pharmaceutical Ingredient Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Small Molecule Active Pharmaceutical Ingredient Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Small Molecule Active Pharmaceutical Ingredient Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Small Molecule Active Pharmaceutical Ingredient Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Small Molecule Active Pharmaceutical Ingredient Market Segments
Table 2. Ranking of Global Top Small Molecule Active Pharmaceutical Ingredient Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Small Molecule Active Pharmaceutical Ingredient Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Standard API
Table 5. Major Manufacturers of High Potency API
Table 6. COVID-19 Impact Global Market: (Four Small Molecule Active Pharmaceutical Ingredient Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Small Molecule Active Pharmaceutical Ingredient Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Small Molecule Active Pharmaceutical Ingredient Players to Combat Covid-19 Impact
Table 11. Global Small Molecule Active Pharmaceutical Ingredient Market Size Growth Rate by Application 2020-2026 (MT)
Table 12. Global Small Molecule Active Pharmaceutical Ingredient Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 13. Global Small Molecule Active Pharmaceutical Ingredient Sales by Regions 2015-2020 (MT)
Table 14. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Regions (2015-2020)
Table 15. Global Small Molecule Active Pharmaceutical Ingredient Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Small Molecule Active Pharmaceutical Ingredient Sales by Manufacturers (2015-2020) (MT)
Table 17. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Manufacturers (2015-2020)
Table 18. Global Small Molecule Active Pharmaceutical Ingredient Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Small Molecule Active Pharmaceutical Ingredient by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Molecule Active Pharmaceutical Ingredient as of 2019)
Table 20. Small Molecule Active Pharmaceutical Ingredient Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Small Molecule Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Small Molecule Active Pharmaceutical Ingredient Price (2015-2020) (USD/MT)
Table 23. Small Molecule Active Pharmaceutical Ingredient Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Small Molecule Active Pharmaceutical Ingredient Product Type
Table 25. Date of International Manufacturers Enter into Small Molecule Active Pharmaceutical Ingredient Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Small Molecule Active Pharmaceutical Ingredient Sales by Type (2015-2020) (MT)
Table 28. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Type (2015-2020)
Table 29. Global Small Molecule Active Pharmaceutical Ingredient Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Small Molecule Active Pharmaceutical Ingredient Revenue Share by Type (2015-2020)
Table 31. Small Molecule Active Pharmaceutical Ingredient Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Small Molecule Active Pharmaceutical Ingredient Sales by Application (2015-2020) (MT)
Table 33. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Application (2015-2020)
Table 34. North America Small Molecule Active Pharmaceutical Ingredient Sales by Country (2015-2020) (MT)
Table 35. North America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)
Table 36. North America Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)
Table 38. North America Small Molecule Active Pharmaceutical Ingredient Sales by Type (2015-2020) (MT)
Table 39. North America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 40. North America Small Molecule Active Pharmaceutical Ingredient Sales by Application (2015-2020) (MT)
Table 41. North America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 42. Europe Small Molecule Active Pharmaceutical Ingredient Sales by Country (2015-2020) (MT)
Table 43. Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)
Table 44. Europe Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)
Table 46. Europe Small Molecule Active Pharmaceutical Ingredient Sales by Type (2015-2020) (MT)
Table 47. Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 48. Europe Small Molecule Active Pharmaceutical Ingredient Sales by Application (2015-2020) (MT)
Table 49. Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales by Region (2015-2020) (MT)
Table 51. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales by Type (2015-2020) (MT)
Table 55. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales by Application (2015-2020) (MT)
Table 57. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 58. Latin America Small Molecule Active Pharmaceutical Ingredient Sales by Country (2015-2020) (MT)
Table 59. Latin America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)
Table 62. Latin America Small Molecule Active Pharmaceutical Ingredient Sales by Type (2015-2020) (MT)
Table 63. Latin America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 64. Latin America Small Molecule Active Pharmaceutical Ingredient Sales by Application (2015-2020) (MT)
Table 65. Latin America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales by Country (2015-2020) (MT)
Table 67. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales by Type (2015-2020) (MT)
Table 71. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales by Application (2015-2020) (MT)
Table 73. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 74. Johnson Matthey Corporation Information
Table 75. Johnson Matthey Description and Major Businesses
Table 76. Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Johnson Matthey Product
Table 78. Johnson Matthey Recent Development
Table 79. Siegfried Holding AG Corporation Information
Table 80. Siegfried Holding AG Description and Major Businesses
Table 81. Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Siegfried Holding AG Product
Table 83. Siegfried Holding AG Recent Development
Table 84. Pfizer Corporation Information
Table 85. Pfizer Description and Major Businesses
Table 86. Pfizer Small Molecule Active Pharmaceutical Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Pfizer Product
Table 88. Pfizer Recent Development
Table 89. Sanofi S.A. Corporation Information
Table 90. Sanofi S.A. Description and Major Businesses
Table 91. Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Sanofi S.A. Product
Table 93. Sanofi S.A. Recent Development
Table 94. Novartis AG, Corporation Information
Table 95. Novartis AG, Description and Major Businesses
Table 96. Novartis AG, Small Molecule Active Pharmaceutical Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Novartis AG, Product
Table 98. Novartis AG, Recent Development
Table 99. Bristol-Myers Squibb Corporation Information
Table 100. Bristol-Myers Squibb Description and Major Businesses
Table 101. Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Bristol-Myers Squibb Product
Table 103. Bristol-Myers Squibb Recent Development
Table 104. Boehringer Ingelheim GmbH Corporation Information
Table 105. Boehringer Ingelheim GmbH Description and Major Businesses
Table 106. Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Boehringer Ingelheim GmbH Product
Table 108. Boehringer Ingelheim GmbH Recent Development
Table 109. GlaxoSmithKline Corporation Information
Table 110. GlaxoSmithKline Description and Major Businesses
Table 111. GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. GlaxoSmithKline Product
Table 113. GlaxoSmithKline Recent Development
Table 114. Albany Molecular Research Inc. Corporation Information
Table 115. Albany Molecular Research Inc. Description and Major Businesses
Table 116. Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Albany Molecular Research Inc. Product
Table 118. Albany Molecular Research Inc. Recent Development
Table 119. Bachem Holding AG Corporation Information
Table 120. Bachem Holding AG Description and Major Businesses
Table 121. Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Bachem Holding AG Product
Table 123. Bachem Holding AG Recent Development
Table 124. PCAS Corporation Information
Table 125. PCAS Description and Major Businesses
Table 126. PCAS Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. PCAS Product
Table 128. PCAS Recent Development
Table 129. Patheon N.V. Corporation Information
Table 130. Patheon N.V. Description and Major Businesses
Table 131. Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. Patheon N.V. Product
Table 133. Patheon N.V. Recent Development
Table 134. AstraZeneca Corporation Information
Table 135. AstraZeneca Description and Major Businesses
Table 136. AstraZeneca Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 137. AstraZeneca Product
Table 138. AstraZeneca Recent Development
Table 139. Johnson & Johnson Corporation Information
Table 140. Johnson & Johnson Description and Major Businesses
Table 141. Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 142. Johnson & Johnson Product
Table 143. Johnson & Johnson Recent Development
Table 144. Merck & Co Corporation Information
Table 145. Merck & Co Description and Major Businesses
Table 146. Merck & Co Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 147. Merck & Co Product
Table 148. Merck & Co Recent Development
Table 149. BASF SE Corporation Information
Table 150. BASF SE Description and Major Businesses
Table 151. BASF SE Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 152. BASF SE Product
Table 153. BASF SE Recent Development
Table 154. Catalent Inc. Corporation Information
Table 155. Catalent Inc. Description and Major Businesses
Table 156. Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 157. Catalent Inc. Product
Table 158. Catalent Inc. Recent Development
Table 159. Teva Pharmaceuticals Corporation Information
Table 160. Teva Pharmaceuticals Description and Major Businesses
Table 161. Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 162. Teva Pharmaceuticals Product
Table 163. Teva Pharmaceuticals Recent Development
Table 164. Roche Corporation Information
Table 165. Roche Description and Major Businesses
Table 166. Roche Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 167. Roche Product
Table 168. Roche Recent Development
Table 169. Cambrex Corporation Corporation Information
Table 170. Cambrex Corporation Description and Major Businesses
Table 171. Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 172. Cambrex Corporation Product
Table 173. Cambrex Corporation Recent Development
Table 174. GILEAD Science Inc. Corporation Information
Table 175. GILEAD Science Inc. Description and Major Businesses
Table 176. GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 177. GILEAD Science Inc. Product
Table 178. GILEAD Science Inc. Recent Development
Table 179. Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Regions (2021-2026) (MT)
Table 180. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share Forecast by Regions (2021-2026)
Table 181. Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 182. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share Forecast by Regions (2021-2026)
Table 183. North America: Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Country (2021-2026) (MT)
Table 184. North America: Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 185. Europe: Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Country (2021-2026) (MT)
Table 186. Europe: Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 187. Asia Pacific: Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Region (2021-2026) (MT)
Table 188. Asia Pacific: Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Region (2021-2026) (US$ Million)
Table 189. Latin America: Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Country (2021-2026) (MT)
Table 190. Latin America: Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 191. Middle East and Africa: Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Country (2021-2026) (MT)
Table 192. Middle East and Africa: Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 193. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 194. Key Challenges
Table 195. Market Risks
Table 196. Main Points Interviewed from Key Small Molecule Active Pharmaceutical Ingredient Players
Table 197. Small Molecule Active Pharmaceutical Ingredient Customers List
Table 198. Small Molecule Active Pharmaceutical Ingredient Distributors List
Table 199. Research Programs/Design for This Report
Table 200. Key Data Information from Secondary Sources
Table 201. Key Data Information from Primary Sources
Table 1. Small Molecule Active Pharmaceutical Ingredient Market Segments
Table 2. Ranking of Global Top Small Molecule Active Pharmaceutical Ingredient Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Small Molecule Active Pharmaceutical Ingredient Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Standard API
Table 5. Major Manufacturers of High Potency API
Table 6. COVID-19 Impact Global Market: (Four Small Molecule Active Pharmaceutical Ingredient Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Small Molecule Active Pharmaceutical Ingredient Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Small Molecule Active Pharmaceutical Ingredient Players to Combat Covid-19 Impact
Table 11. Global Small Molecule Active Pharmaceutical Ingredient Market Size Growth Rate by Application 2020-2026 (MT)
Table 12. Global Small Molecule Active Pharmaceutical Ingredient Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 13. Global Small Molecule Active Pharmaceutical Ingredient Sales by Regions 2015-2020 (MT)
Table 14. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Regions (2015-2020)
Table 15. Global Small Molecule Active Pharmaceutical Ingredient Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Small Molecule Active Pharmaceutical Ingredient Sales by Manufacturers (2015-2020) (MT)
Table 17. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Manufacturers (2015-2020)
Table 18. Global Small Molecule Active Pharmaceutical Ingredient Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Small Molecule Active Pharmaceutical Ingredient by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Molecule Active Pharmaceutical Ingredient as of 2019)
Table 20. Small Molecule Active Pharmaceutical Ingredient Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Small Molecule Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Small Molecule Active Pharmaceutical Ingredient Price (2015-2020) (USD/MT)
Table 23. Small Molecule Active Pharmaceutical Ingredient Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Small Molecule Active Pharmaceutical Ingredient Product Type
Table 25. Date of International Manufacturers Enter into Small Molecule Active Pharmaceutical Ingredient Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Small Molecule Active Pharmaceutical Ingredient Sales by Type (2015-2020) (MT)
Table 28. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Type (2015-2020)
Table 29. Global Small Molecule Active Pharmaceutical Ingredient Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Small Molecule Active Pharmaceutical Ingredient Revenue Share by Type (2015-2020)
Table 31. Small Molecule Active Pharmaceutical Ingredient Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Small Molecule Active Pharmaceutical Ingredient Sales by Application (2015-2020) (MT)
Table 33. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Application (2015-2020)
Table 34. North America Small Molecule Active Pharmaceutical Ingredient Sales by Country (2015-2020) (MT)
Table 35. North America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)
Table 36. North America Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)
Table 38. North America Small Molecule Active Pharmaceutical Ingredient Sales by Type (2015-2020) (MT)
Table 39. North America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 40. North America Small Molecule Active Pharmaceutical Ingredient Sales by Application (2015-2020) (MT)
Table 41. North America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 42. Europe Small Molecule Active Pharmaceutical Ingredient Sales by Country (2015-2020) (MT)
Table 43. Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)
Table 44. Europe Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)
Table 46. Europe Small Molecule Active Pharmaceutical Ingredient Sales by Type (2015-2020) (MT)
Table 47. Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 48. Europe Small Molecule Active Pharmaceutical Ingredient Sales by Application (2015-2020) (MT)
Table 49. Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales by Region (2015-2020) (MT)
Table 51. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales by Type (2015-2020) (MT)
Table 55. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales by Application (2015-2020) (MT)
Table 57. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 58. Latin America Small Molecule Active Pharmaceutical Ingredient Sales by Country (2015-2020) (MT)
Table 59. Latin America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)
Table 62. Latin America Small Molecule Active Pharmaceutical Ingredient Sales by Type (2015-2020) (MT)
Table 63. Latin America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 64. Latin America Small Molecule Active Pharmaceutical Ingredient Sales by Application (2015-2020) (MT)
Table 65. Latin America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales by Country (2015-2020) (MT)
Table 67. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales by Type (2015-2020) (MT)
Table 71. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales by Application (2015-2020) (MT)
Table 73. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 74. Johnson Matthey Corporation Information
Table 75. Johnson Matthey Description and Major Businesses
Table 76. Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Johnson Matthey Product
Table 78. Johnson Matthey Recent Development
Table 79. Siegfried Holding AG Corporation Information
Table 80. Siegfried Holding AG Description and Major Businesses
Table 81. Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Siegfried Holding AG Product
Table 83. Siegfried Holding AG Recent Development
Table 84. Pfizer Corporation Information
Table 85. Pfizer Description and Major Businesses
Table 86. Pfizer Small Molecule Active Pharmaceutical Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Pfizer Product
Table 88. Pfizer Recent Development
Table 89. Sanofi S.A. Corporation Information
Table 90. Sanofi S.A. Description and Major Businesses
Table 91. Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Sanofi S.A. Product
Table 93. Sanofi S.A. Recent Development
Table 94. Novartis AG, Corporation Information
Table 95. Novartis AG, Description and Major Businesses
Table 96. Novartis AG, Small Molecule Active Pharmaceutical Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Novartis AG, Product
Table 98. Novartis AG, Recent Development
Table 99. Bristol-Myers Squibb Corporation Information
Table 100. Bristol-Myers Squibb Description and Major Businesses
Table 101. Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Bristol-Myers Squibb Product
Table 103. Bristol-Myers Squibb Recent Development
Table 104. Boehringer Ingelheim GmbH Corporation Information
Table 105. Boehringer Ingelheim GmbH Description and Major Businesses
Table 106. Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Boehringer Ingelheim GmbH Product
Table 108. Boehringer Ingelheim GmbH Recent Development
Table 109. GlaxoSmithKline Corporation Information
Table 110. GlaxoSmithKline Description and Major Businesses
Table 111. GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. GlaxoSmithKline Product
Table 113. GlaxoSmithKline Recent Development
Table 114. Albany Molecular Research Inc. Corporation Information
Table 115. Albany Molecular Research Inc. Description and Major Businesses
Table 116. Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Albany Molecular Research Inc. Product
Table 118. Albany Molecular Research Inc. Recent Development
Table 119. Bachem Holding AG Corporation Information
Table 120. Bachem Holding AG Description and Major Businesses
Table 121. Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Bachem Holding AG Product
Table 123. Bachem Holding AG Recent Development
Table 124. PCAS Corporation Information
Table 125. PCAS Description and Major Businesses
Table 126. PCAS Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. PCAS Product
Table 128. PCAS Recent Development
Table 129. Patheon N.V. Corporation Information
Table 130. Patheon N.V. Description and Major Businesses
Table 131. Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. Patheon N.V. Product
Table 133. Patheon N.V. Recent Development
Table 134. AstraZeneca Corporation Information
Table 135. AstraZeneca Description and Major Businesses
Table 136. AstraZeneca Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 137. AstraZeneca Product
Table 138. AstraZeneca Recent Development
Table 139. Johnson & Johnson Corporation Information
Table 140. Johnson & Johnson Description and Major Businesses
Table 141. Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 142. Johnson & Johnson Product
Table 143. Johnson & Johnson Recent Development
Table 144. Merck & Co Corporation Information
Table 145. Merck & Co Description and Major Businesses
Table 146. Merck & Co Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 147. Merck & Co Product
Table 148. Merck & Co Recent Development
Table 149. BASF SE Corporation Information
Table 150. BASF SE Description and Major Businesses
Table 151. BASF SE Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 152. BASF SE Product
Table 153. BASF SE Recent Development
Table 154. Catalent Inc. Corporation Information
Table 155. Catalent Inc. Description and Major Businesses
Table 156. Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 157. Catalent Inc. Product
Table 158. Catalent Inc. Recent Development
Table 159. Teva Pharmaceuticals Corporation Information
Table 160. Teva Pharmaceuticals Description and Major Businesses
Table 161. Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 162. Teva Pharmaceuticals Product
Table 163. Teva Pharmaceuticals Recent Development
Table 164. Roche Corporation Information
Table 165. Roche Description and Major Businesses
Table 166. Roche Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 167. Roche Product
Table 168. Roche Recent Development
Table 169. Cambrex Corporation Corporation Information
Table 170. Cambrex Corporation Description and Major Businesses
Table 171. Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 172. Cambrex Corporation Product
Table 173. Cambrex Corporation Recent Development
Table 174. GILEAD Science Inc. Corporation Information
Table 175. GILEAD Science Inc. Description and Major Businesses
Table 176. GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 177. GILEAD Science Inc. Product
Table 178. GILEAD Science Inc. Recent Development
Table 179. Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Regions (2021-2026) (MT)
Table 180. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share Forecast by Regions (2021-2026)
Table 181. Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 182. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share Forecast by Regions (2021-2026)
Table 183. North America: Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Country (2021-2026) (MT)
Table 184. North America: Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 185. Europe: Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Country (2021-2026) (MT)
Table 186. Europe: Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 187. Asia Pacific: Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Region (2021-2026) (MT)
Table 188. Asia Pacific: Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Region (2021-2026) (US$ Million)
Table 189. Latin America: Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Country (2021-2026) (MT)
Table 190. Latin America: Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 191. Middle East and Africa: Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Country (2021-2026) (MT)
Table 192. Middle East and Africa: Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 193. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 194. Key Challenges
Table 195. Market Risks
Table 196. Main Points Interviewed from Key Small Molecule Active Pharmaceutical Ingredient Players
Table 197. Small Molecule Active Pharmaceutical Ingredient Customers List
Table 198. Small Molecule Active Pharmaceutical Ingredient Distributors List
Table 199. Research Programs/Design for This Report
Table 200. Key Data Information from Secondary Sources
Table 201. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Small Molecule Active Pharmaceutical Ingredient Product Picture
Figure 2. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type in 2020 & 2026
Figure 3. Standard API Product Picture
Figure 4. High Potency API Product Picture
Figure 5. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application in 2020 & 2026
Figure 6. Cardiovascular Diseases
Figure 7. Respiratory Disorders
Figure 8. Infectious Diseases
Figure 9. Others
Figure 10. Small Molecule Active Pharmaceutical Ingredient Report Years Considered
Figure 11. Global Small Molecule Active Pharmaceutical Ingredient Market Size 2015-2026 (US$ Million)
Figure 12. Global Small Molecule Active Pharmaceutical Ingredient Sales 2015-2026 (MT)
Figure 13. Global Small Molecule Active Pharmaceutical Ingredient Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Region (2015-2020)
Figure 15. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Region in 2019
Figure 16. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Region (2015-2020)
Figure 17. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Region in 2019
Figure 18. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Small Molecule Active Pharmaceutical Ingredient Revenue in 2019
Figure 20. Small Molecule Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Figure 22. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type in 2019
Figure 23. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Type (2015-2020)
Figure 24. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Type in 2019
Figure 25. Global Small Molecule Active Pharmaceutical Ingredient Market Share by Price Range (2015-2020)
Figure 26. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Figure 27. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application in 2019
Figure 28. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Application (2015-2020)
Figure 29. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Application in 2019
Figure 30. North America Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (MT)
Figure 31. North America Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country in 2019
Figure 33. North America Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country in 2019
Figure 34. U.S. Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 35. U.S. Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 37. Canada Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Small Molecule Active Pharmaceutical Ingredient Market Share by Type in 2019
Figure 39. North America Small Molecule Active Pharmaceutical Ingredient Market Share by Application in 2019
Figure 40. Europe Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (MT)
Figure 41. Europe Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country in 2019
Figure 43. Europe Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country in 2019
Figure 44. Germany Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 45. Germany Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 47. France Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 49. U.K. Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 51. Italy Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 53. Russia Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Small Molecule Active Pharmaceutical Ingredient Market Share by Type in 2019
Figure 55. Europe Small Molecule Active Pharmaceutical Ingredient Market Share by Application in 2019
Figure 56. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (MT)
Figure 57. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Region in 2019
Figure 59. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Region in 2019
Figure 60. China Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 61. China Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 63. Japan Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 65. South Korea Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 67. India Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 69. Australia Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 71. Taiwan Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 73. Indonesia Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 75. Thailand Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 77. Malaysia Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 79. Philippines Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 81. Vietnam Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Market Share by Type in 2019
Figure 83. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Market Share by Application in 2019
Figure 84. Latin America Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (MT)
Figure 85. Latin America Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country in 2019
Figure 87. Latin America Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country in 2019
Figure 88. Mexico Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 89. Mexico Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 91. Brazil Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 93. Argentina Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Small Molecule Active Pharmaceutical Ingredient Market Share by Type in 2019
Figure 95. Latin America Small Molecule Active Pharmaceutical Ingredient Market Share by Application in 2019
Figure 96. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (MT)
Figure 97. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country in 2019
Figure 100. Turkey Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 101. Turkey Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 103. Saudi Arabia Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 105. U.A.E Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Market Share by Type in 2019
Figure 107. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Market Share by Application in 2019
Figure 108. Johnson Matthey Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Siegfried Holding AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Sanofi S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Novartis AG, Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Boehringer Ingelheim GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Albany Molecular Research Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Bachem Holding AG
Figure 1. Small Molecule Active Pharmaceutical Ingredient Product Picture
Figure 2. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type in 2020 & 2026
Figure 3. Standard API Product Picture
Figure 4. High Potency API Product Picture
Figure 5. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application in 2020 & 2026
Figure 6. Cardiovascular Diseases
Figure 7. Respiratory Disorders
Figure 8. Infectious Diseases
Figure 9. Others
Figure 10. Small Molecule Active Pharmaceutical Ingredient Report Years Considered
Figure 11. Global Small Molecule Active Pharmaceutical Ingredient Market Size 2015-2026 (US$ Million)
Figure 12. Global Small Molecule Active Pharmaceutical Ingredient Sales 2015-2026 (MT)
Figure 13. Global Small Molecule Active Pharmaceutical Ingredient Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Region (2015-2020)
Figure 15. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Region in 2019
Figure 16. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Region (2015-2020)
Figure 17. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Region in 2019
Figure 18. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Small Molecule Active Pharmaceutical Ingredient Revenue in 2019
Figure 20. Small Molecule Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Figure 22. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type in 2019
Figure 23. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Type (2015-2020)
Figure 24. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Type in 2019
Figure 25. Global Small Molecule Active Pharmaceutical Ingredient Market Share by Price Range (2015-2020)
Figure 26. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Figure 27. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application in 2019
Figure 28. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Application (2015-2020)
Figure 29. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Application in 2019
Figure 30. North America Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (MT)
Figure 31. North America Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country in 2019
Figure 33. North America Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country in 2019
Figure 34. U.S. Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 35. U.S. Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 37. Canada Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Small Molecule Active Pharmaceutical Ingredient Market Share by Type in 2019
Figure 39. North America Small Molecule Active Pharmaceutical Ingredient Market Share by Application in 2019
Figure 40. Europe Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (MT)
Figure 41. Europe Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country in 2019
Figure 43. Europe Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country in 2019
Figure 44. Germany Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 45. Germany Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 47. France Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 49. U.K. Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 51. Italy Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 53. Russia Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Small Molecule Active Pharmaceutical Ingredient Market Share by Type in 2019
Figure 55. Europe Small Molecule Active Pharmaceutical Ingredient Market Share by Application in 2019
Figure 56. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (MT)
Figure 57. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Region in 2019
Figure 59. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Region in 2019
Figure 60. China Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 61. China Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 63. Japan Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 65. South Korea Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 67. India Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 69. Australia Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 71. Taiwan Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 73. Indonesia Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 75. Thailand Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 77. Malaysia Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 79. Philippines Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 81. Vietnam Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Market Share by Type in 2019
Figure 83. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Market Share by Application in 2019
Figure 84. Latin America Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (MT)
Figure 85. Latin America Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country in 2019
Figure 87. Latin America Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country in 2019
Figure 88. Mexico Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 89. Mexico Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 91. Brazil Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 93. Argentina Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Small Molecule Active Pharmaceutical Ingredient Market Share by Type in 2019
Figure 95. Latin America Small Molecule Active Pharmaceutical Ingredient Market Share by Application in 2019
Figure 96. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (MT)
Figure 97. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country in 2019
Figure 100. Turkey Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 101. Turkey Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 103. Saudi Arabia Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)
Figure 105. U.A.E Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Market Share by Type in 2019
Figure 107. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Market Share by Application in 2019
Figure 108. Johnson Matthey Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Siegfried Holding AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Sanofi S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Novartis AG, Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Boehringer Ingelheim GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Albany Molecular Research Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Bachem Holding AG
